These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18842531)

  • 1. Uncertainty after treatment for prostate cancer: definition, assessment, and management.
    Yu Ko WF; Degner LF
    Clin J Oncol Nurs; 2008 Oct; 12(5):749-55. PubMed ID: 18842531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Watching, waiting and uncertainty in prostate cancer.
    Bailey DE; Wallace M; Mishel MH
    J Clin Nurs; 2007 Apr; 16(4):734-41. PubMed ID: 17402955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the concept of uncertainty in patients with indolent lymphoma.
    Elphee EE
    Oncol Nurs Forum; 2008 May; 35(3):449-54. PubMed ID: 18467294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer.
    Oliffe JL; Davison BJ; Pickles T; Mróz L
    Qual Health Res; 2009 Apr; 19(4):432-43. PubMed ID: 19229061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding more meaning: the antecedents of uncertainty revisited.
    Wallace M
    J Clin Nurs; 2005 Aug; 14(7):863-8. PubMed ID: 16000100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatments for localized prostate cancer.
    Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer overview.
    Dunn MW; Kazer MW
    Semin Oncol Nurs; 2011 Nov; 27(4):241-50. PubMed ID: 22018403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-centered comparative effectiveness research: essential for high-quality care.
    Slutsky JR; Clancy CM
    Arch Intern Med; 2010 Mar; 170(5):403-4. PubMed ID: 20212173
    [No Abstract]   [Full Text] [Related]  

  • 11. Working patterns and perceived contribution of prostate cancer clinical nurse specialists: a mixed method investigation.
    Ream E; Wilson-Barnett J; Faithfull S; Fincham L; Khoo V; Richardson A
    Int J Nurs Stud; 2009 Oct; 46(10):1345-54. PubMed ID: 19358991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer in Canada.
    Estey EP
    In Vivo; 1994; 8(3):437-8. PubMed ID: 7803730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life after cancer.
    Wyatt E
    ONS Connect; 2009 Jun; 24(6):8-11. PubMed ID: 19552186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk prostate cancer: evolving definition and approach to management.
    Chughtai B; Mian BM
    Can J Urol; 2008 Dec; 15(6):4375-80. PubMed ID: 19046490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model linking uncertainty, post-traumatic stress, and health behaviors in childhood cancer survivors.
    Lee YL; Gau BS; Hsu WM; Chang HH
    Oncol Nurs Forum; 2009 Jan; 36(1):E20-30. PubMed ID: 19136328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC; Saigal CS
    Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies in castrate-resistant prostate cancer.
    Lassi K; Dawson NA
    Curr Opin Oncol; 2009 May; 21(3):260-5. PubMed ID: 19363343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH; Roobol MJ
    Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer in the elderly.
    Heinzer H; Steuber T
    Urol Oncol; 2009; 27(6):668-72. PubMed ID: 19879477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.